The Max Foundation is pleased to welcome Curt Malloy as the newest member of our Executive Board. Curt, a fellow advocate for people facing cancer around the world, has been a strong supporter of our work for many years throughout his active engagement in global health.
Curt currently serves as the Chief Operating Officer at Cancer Research And Biostatistics (CRAB) in Seattle, where he leads data management, project management, clinical monitoring, and regulatory. He is a co-leader of CRAB’s Latin America Initiative, which was formed with the intention of providing clinical research training programs for clinical investigators and statisticians in Latin America and identifying clinical research opportunities.
Prior to joining CRAB, Curt was the operational leader for the Fred Hutch Vaccine and Infectious Disease Division, while also serving on the boards of their global research initiatives in South Africa, Uganda, and China. Prior to the Fred Hutch, Curt served for ten years in various leadership positions at the Infectious Disease Research Institute. Curt has a Masters of Public Health from Columbia University School of Public Health and earned a Juris Doctor with a focus on intellectual property from Seattle University School of Law. He is fluent in Spanish and is particularly passionate about Latin America, social and health equity and planetary health.
Pat Garcia-Gonzalez, CEO of The Max Foundation said of Curt’s appointment, “It is well known that The Max Foundation has a strong historical connection to Latin America given that helping families there was the focus of our original mission. Curt has an impressive background that promises to only strengthen our resolve in serving cancer patients in Latin America and across the globe.”
We are thrilled to be able to leverage Curt’s deep experience serving on NGO boards, his expertise in the field of cancer research, and his strong commitment to global health—all to bring dignity and hope to people facing cancer around the world.
The Max Foundation is a leading global health nonprofit organization dedicated to accelerating health equity. For 28 years, Max has pioneered practical, scalable, high-quality solutions to bring life-extending treatments and patient-centered health care to more than 100,000 people living with cancer and critical illness in low- and middle-income countries. Max believes in a world where all people can access high-impact medicines, where geography is not destiny, and where everyone can strive for health with dignity and with hope.
The numbers are in! The Max Foundation is thrilled to announce that Spot On CML, our diagnostic collaboration with Fred Hutchinson Cancer Research Center, has provided free testing to 371 patients across 15 countries in its inaugural year.
Earlier this month, The Max Foundation celebrated the delivery of 110 BCR-ABL molecular tests to Mercy Medical Center Cambodia. The delivery was the first of its kind for Max, made possible through our 2018 Diagnostics Solidarity Fund. Two more deliveries – one to Kyrgyzstan and one to Bolivia – are in process now, and we’re hopeful there will be many more to come.
We are delighted to announce that Bryan Murphy-Eustis, MBA, MPH, is joining The Max Foundation’s Executive Team as Vice President of Programs. Bryan joins the team with more than 18 years of experience building and leading high-impact mission-driven teams, most recently as Commercialization Lead for Medical Technologies at Global Good at Intellectual Ventures. Previously he….
